Related Experiment Videos

Negative micronucleus tests on caprolactam and benzoin in ICR/JCL male mice

M Ishidate1, Y Odagiri

  • 1National Institute of Hygienic Sciences, Tokyo, Japan.

Mutation Research
|November 1, 1989
PubMed

Insights

This study investigated the genotoxicity of caprolactam (CAP) and benzoin (ZOIN) in mice. Neither chemical significantly increased micronucleated polychromatic erythrocytes, suggesting no significant bone marrow damage.

Area of Science:

  • Toxicology
  • Genetics
  • Mammalian Studies

Background:

  • Caprolactam (CAP) and benzoin (ZOIN) are industrial chemicals with potential health implications.
  • Assessing the genotoxic potential of these compounds is crucial for understanding their safety profile.

Purpose of the Study:

  • To evaluate the in vivo genotoxicity of caprolactam and benzoin.
  • To determine if these chemicals induce chromosomal damage in mouse bone marrow cells.

Main Methods:

  • Male ICR/JCL mice were administered varying doses of caprolactam or benzoin via intraperitoneal injection.
  • Bone marrow samples were collected at different time points (24, 30, and 48 hours) post-administration.
  • Micronucleated polychromatic erythrocytes assay was performed to assess genotoxicity.

Main Results:

  • No statistically significant increase in the incidence of micronucleated polychromatic erythrocytes was observed in mice treated with caprolactam.
  • Similarly, benzoin treatment did not lead to a significant increase in micronucleated polychromatic erythrocytes.
  • These findings indicate a lack of clastogenic or aneugenic effects at the tested doses.

Conclusions:

  • Caprolactam and benzoin do not appear to be genotoxic in the mouse bone marrow micronucleus test.
  • Further research may be warranted to explore other potential toxicological endpoints.
  • The study suggests a low risk of chromosomal damage from acute exposure to these chemicals.

Related Concept Videos